10
Apr

San Diego-based Celladon has nabbed a “breakthrough” drug designation from the FDA for its heart failure drug Mydicar. The gene therapy uses a benign virus to insert the Serca2a gene into heart cells.

…read more

Source: UPDATED: Celladon’s heart drug grabs ‘breakthrough’ status at FDA

    

0 No comments